How should clinicians and patients choose antihyperglycemic agents? An evidence-based approach

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The choice of antihyperglycemic agents has become more complex as new drug classes have appeared and evidence about their efficacy and safety accumulates. Unfortunately, direct and fair comparisons are lacking and the clinician and patient are left to decide among agents with different safety and burden profiles. Furthermore, the relative efficacy of these agents beyond their ability to lower hemoglobin A1c - that is, in their ability to reduce the risk of diabetes complications - remains uncertain. In this sea of uncertainty, interests other than those of the patient actively shape choices. It is our expectation that better evidence, better policy and better decisions will eventually become routine in the care of patients with diabetes. Copyright by Medycyna Praktyczna, 2011.

Original languageEnglish (US)
Pages (from-to)208-212
Number of pages5
JournalPolskie Archiwum Medycyny Wewnetrznej
Volume121
Issue number6
StatePublished - 2011

Keywords

  • Antihyperglycemic agents
  • Clinical decision making
  • Patient-centered care
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'How should clinicians and patients choose antihyperglycemic agents? An evidence-based approach'. Together they form a unique fingerprint.

  • Cite this